Associate Chief Physician. He mainly engages in research on pediatric neurological diseases. He has published more than 30 papers in domestic and international academic journals, among which several are indexed in SCI. He participated in compiling two books entitled Treatable Rare Diseases. He presided over and participated in a number of national and provincial Natural Science Foundation projects as well as hospital-level foundation projects.

Research Projects:

1. Hainan Provincial Natural Science Foundation, No.824MS167, Molecular Mechanism of Rapamycin and Callicarpa Nudiflora in the Treatment of Neurodevelopmental Disorders Based on the mTORC2 Signaling Pathway, 2024-03-01 to 2027-02-28, Principal Investigator.

2. National Natural Science Foundation of China Youth Program, The Role of Signaling Axis in Neuronal Apoptosis after Hypoxic-Ischemic Brain Injury in Neonatal Rats, No.81801488, 2019-01 to 2021-12, Co-Investigator.

3. Hospital-level Foundation Project of Shanghai Children's Medical Center, Detection of mTORC1 Activity and Evaluation of Rapamycin Efficacy in Patients with mTOR-Target Related Refractory Epilepsy, 2019/07-2021/07, Principal Investigator.

He specializes in the diagnosis and treatment of common and frequently-occurring pediatric neurological disorders, as well as rare neurological diseases, including epilepsy, febrile convulsions, developmental disorders, myopathy and myositis, encephalitis, tic disorders, tuberous sclerosis, etc.